Premature ovarian failure

Hormone Research

Volumn 68, Issue 4, 2007, Pages 196-202

  Goswami, Deepti ^a   Conway, Gerard S ^b,c  

^a MAULANA AZAD MEDICAL COLLEGE   (India)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^c UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Amenorrhoea; Follicle stimulating hormone; Hormone replacement therapy; Infertility treatment; Premature ovarian failure

Indexed keywords

ANTINEOPLASTIC AGENT; CONJUGATED ESTROGEN; ESTRADIOL; ESTROGEN; FOLLITROPIN;

AMENORRHEA; AUTOIMMUNE DISEASE; BIOPSY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CAUSAL ATTRIBUTION; CRYOPRESERVATION; DISEASE MARKER; DOWN SYNDROME; ECHOGRAPHY; FOLLITROPIN BLOOD LEVEL; GENE LOCUS; GENETIC ASSOCIATION; HORMONE SUBSTITUTION; HUMAN; INFERTILITY; INFERTILITY THERAPY; KARYOTYPING; MENOPAUSE; ONSET AGE; OOCYTE; OOCYTE DONATION; PATHOGENESIS; PREMATURE OVARIAN FAILURE; PRIMARY AMENORRHEA; PRIORITY JOURNAL; SHORT SURVEY; TURNER SYNDROME; X CHROMOSOME ABERRATION; AUTOIMMUNITY; FEMALE; FEMALE INFERTILITY; GENETIC DISORDER; GENETICS; PSYCHOLOGICAL ASPECT; REVIEW; X CHROMOSOME LINKED DISORDER;

AUTOIMMUNITY; DOWN SYNDROME; FEMALE; GENETIC DISEASES, INBORN; GENETIC DISEASES, X-LINKED; HORMONE REPLACEMENT THERAPY; HUMANS; INFERTILITY, FEMALE; OVARIAN FAILURE, PREMATURE; TURNER SYNDROME;

EID: 35248872162     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000102537     Document Type: Short Survey

References (65)

1. McKinlay SM, Brambilla DJ, Posner JG: The normal menopause transition. Maturitas 1992;14:103-115.
2. Snieder H, MacGregor AJ, Spector TD: Genes control the cessation of a woman's reproductive life: a twin study of hysterectomy and age at menopause. J Clin Endocrinol Metab 1998;83:1875-1880.
3. McKinlay SM: The normal menopause transition: an overview. Maturitas 1996;23:137-145.
4. Torgerson DJ, Thomas RE, Reid DM: Mothers and daughters menopausal ages: is there a link? Eur J Obstet Gynecol Reprod Biol 1997;74:63-66.
5. Luborsky JL, Meyer P, Sowers MF, Gold EB, Santoro N: Premature menopause in a multiethnic population study of the menopause transition. Hum Reprod 2003;18:199-206.
6. Coulam CB, Adamson SC, Annegers JF: Incidence of premature ovarian failure. Obstet Gynecol 1986;67:604-606.
7. Anasti JN: Premature ovarian failure: an update. Fertil Steril 1998;70:1-15.
8. van Kasteren YM, Hundscheid RD, Smits AP, Cremers FP, van Zonneveld P, Braat DD: Familial idiopathic premature ovarian failure: an overrated and underestimated genetic disease? Hum Reprod 1999;14:2455-2459.
9. Conway GS, Payne NN, Webb J, Murray A, Jacobs PA: Fragile X premutation screening in women with premature ovarian failure. Hum Reprod 1998;13:1184-1187.
10. Laml T, Schulz-Lobmeyr I, Obruca A, Huber JC, Hartmann BW: Premature ovarian failure: etiology and prospects. Gynecol Endocrinol 2000;14:292-302.
11. Pal L, Santoro N: Premature ovarian failure (POF): discordance between somatic and reproductive aging. Ageing Res Rev 2002;1:413-423.
12. Goswami R, Goswami D, Kabra M, Gupta N, Dubey S, Dadhwal V: Prevalence of the triple X syndrome in phenotypically normal women with premature ovarian failure and its association with autoimmune thyroid disorders. Fertil Steril 2003;80:1052-1054.
13. Eggermann T, Meschede D, Schuler H, et al: Premature ovarian failure associated with a small terminal Xq deletion: narrowing the POF1 region down to Xq27.2/Xq27.3-qter. Clin Genet 2005;67:434-437.
14. Powell CM, Taggart RT, Drumheller TC, et al: Molecular and cytogenetic studies of an X; autosome translocation in a patient with premature ovarian failure and review of the literature. Am J Med Genet 1994;52:19-26.
15. Davison RM, Fox M, Conway GS: Mapping of the POF1 locus and identification of putative genes for premature ovarian failure. Mol Hum Reprod 2000;6:314-318.
16. Sala C, Arrigo G, Torri G, et al: Eleven X chromosome breakpoints associated with premature ovarian failure (POF) map to a 15-Mb YAC contig spanning Xq21. Genomics 1997;40:123-131.
17. Therman E, Laxova R, Susman B: The critical region on the human Xq. Hum Genet 1990;85:455-461.
18. Schupf N, Zigman W, Kapell D, Lee JH, Kline J, Levin B: Early menopause in women with Down's syndrome. J Intellect Disabil Res 1997;41:264-267.
19. Goswami D, Conway GS: Premature ovarian failure. Hum Reprod Update 2005;11:391-410.
20. Conway GS, Kaltsas G, Patel A, Davies MC, Jacobs HS: Characterization of idiopathic premature ovarian failure. Fertil Steril 1996;65:337-341.
21. Forges T, Monnier-Barbarino P, Faure GC, Bene MC: Autoimmunity and antigenic targets in ovarian pathology. Hum Reprod Update 2004;10:163-175.
22. Hoek A, Schoemaker J, Drexhage HA: Premature ovarian failure and ovarian autoimmunity. Endocr Rev 1997;18:107-134.
23. Doldi N, Belvisi L, Bassan M, Fusi FM, Ferrari A: Premature ovarian failure: steroid synthesis and autoimmunity. Gynecol Endocrinol 1998;12:23-28.
24. Belvisi L, Bombelli F, Sironi L, Doldi N: Organ-specific autoimmunity in patients with premature ovarian failure. J Endocrinol Invest 1993;16:889-892.
25. Goswami R, Marwaha RK, Goswami D, et al: Prevalence of thyroid autoimmunity in sporadic idiopathic hypoparathyroidism in comparison to type 1 diabetes and premature ovarian failure. J Clin Endocrinol Metab 2006;91:4256-4259.
26. Bakalov VK, Vanderhoof VH, Bondy CA, Nelson LM: Adrenal antibodies detect asymptomatic auto-immune adrenal insufficiency in young women with spontaneous premature ovarian failure. Hum Reprod 2002;17:2096-2100.
27. Kauffman RP, Castracane VD: Premature ovarian failure associated with autoimmune polyglandular syndrome: pathophysiological mechanisms and future fertility. J Womens Health (Larchmt.) 2003;12:513-520.
28. Melner MH, Feltus FA: Autoimmune premature ovarian failure - endocrine aspects of a T cell disease. Endocrinology 1999;140:3401-3403.
29. Wheatcroft NJ, Salt C, Milford-Ward A, Cooke ID, Weetman AP: Identification of ovarian antibodies by immunofluorescence, enzyme-linked immunosorbent assay or immunoblotting in premature ovarian failure. Hum Reprod 1997;12:2617-2622.
30. Nelson LM: Autoimmune ovarian failure: comparing the mouse model and the human disease. J Soc Gynecol Investig 2001;8:S55-S57.
31. Tong ZB, Nelson LM: A mouse gene encoding an oocyte antigen associated with autoimmune premature ovarian failure. Endocrinology 1999;140:3720-3726.
32. Tong ZB, Bondy CA, Zhou J, Nelson LM: A human homologue of mouse Mater, a maternal effect gene essential for early embryonic development. Hum Reprod 2002;17:903-911.
33. Morrison JC, Givens JR, Wiser WL, Fish SA: Mumps oophoritis: a cause of premature menopause. Fertil Steril 1975;26:655-659.
34. Di Prospero F, Luzi S, Iacopini Z: Cigarette smoking damages women's reproductive life. Reprod Biomed Online 2004;8:246-247.
35. Klein P, Serje A, Pezzullo JC: Premature ovarian failure in women with epilepsy. Epilepsia 2001;42:1584-1589.
36. Sharara FI, Seifer DB, Flaws JA: Environmental toxicants and female reproduction. Fertil Steril 1998;70:613-622.
37. Lushbaugh CC, Casarett GW: The effects of gonadal irradiation in clinical radiation therapy: a review. Cancer 1976;37:1111-1125.
38. Beerendonk CC, Braat DD: Present and future options for the preservation of fertility in female adolescents with cancer. Endocr Dev 2005;8:166-175.
39. Madsen BL, Giudice L, Donaldson SS: Radiation-induced premature menopause: a misconception. Int J Radiat Oncol Biol Phys 1995;32:1461-1464.
40. Morice P, Juncker L, Rey A, El-Hassan J, Haie-Meder C, Castaigne D: Ovarian transposition for patients with cervical carcinoma treated by radiosurgical combination. Fertil Steril 2000;74:743-748.
41. Byrne J, Fears TR, Gail MH, et al: Early menopause in long-term survivors of cancer during adolescence. Am J Obstet Gynecol 1992;166:788-793.
42. Larsen EC, Muller J, Schmiegelow K, Rechnitzer C, Andersen AN: Reduced ovarian function in long-term survivors of radiation-and chemotherapy-treated childhood cancer. J Clin Endocrinol Metab 2003;88:5307-5314.
43. Hascalik S, Celik O, Sarac K, Hascalik M: Transient ovarian failure: a rare complication of uterine fibroid embolization. Acta Obstet Gynecol Scand 2004;83:682-685.
44. Nelson HD: Commonly used types of postmenopausal estrogen for treatment of hot flashes: scientific review. JAMA 2004;7:1610-1620.
45. Henzl MR, Loomba PK: Transdermal delivery of sex steroids for hormone replacement therapy and contraception. A review of principles and practice. J Reprod Med 2003;48:525-540.
46. Scarabin PY, Oger E, Plu-Bureau G: Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk. Lancet 2003;362:428-432.
47. Jones SC: Subcutaneous estrogen replacement therapy. J Reprod Med 2004;49:139-142.
48. Suckling J, Lethaby A, Kennedy R: Local oestrogen for vaginal atrophy in postmenopausal women. Cochrane Database Syst Rev 2003;4:CD001500.
49. Chlebowski RT, Hendrix SL, Langer RD, et al: Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial. JAMA 2003;289:3243-3253.
50. Beral V: Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 2003;362:419-427.
51. Davis SR, Burger HG: The role of androgen therapy. Best Pract Res Clin Endocrinol Metab 2003;17:165-175.
52. Arlt W: Androgen therapy in women. Eur J Endocrinol 2006;154:1-11.
53. van Kasteren YM, Schoemaker J: Premature ovarian failure: a systematic review on therapeutic interventions to restore ovarian function and achieve pregnancy. Hum Reprod Update 1999;5:483-492.
54. Rotsztejn DA, Remohi J, Weckstein LN, et al: Results of tubal embryo transfer in premature ovarian failure. Fertil Steril 1990;54:348-350.
55. Abdalla HI, Baber RJ, Kirkland A, Leonard T, Studd JW: Pregnancy in women with premature ovarian failure using tubal and intrauterine transfer of cryopreserved zygotes. Br J Obstet Gynaecol 1989;96:1071-1075.
56. Silber SJ, Lenahan KM, Levine DJ, et al: Ovarian transplantation between monozygotic twins discordant for premature ovarian failure. N Engl J Med 2005;353:58-63.
57. Poirot C, Vacher-Lavenu MC, Helardot P, Guibert J, Brugieres L, Jouannet P: Human ovarian tissue cryopreservation: indications and feasibility. Hum Reprod 2002;17:1447-1452.
58. Donnez J, Dolmans MM, Demylle D, et al: Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet 2004;364:1405-1410.
59. Borini A, Bonu MA, Coticchio G, Bianchi V, Cattoli M, Flamigni C: Pregnancies and births after oocyte cryopreservation. Fertil Steril 2004;82:601-605.
60. Lucena E, Bernal DP, Lucena C, Rojas A, Moran A, Lucena A: Successful ongoing pregnancies after vitrification of oocytes. Fertil Steril 2006;85:108-111.
61. Rao GD, Tan SL: In vitro maturation of oocytes. Semin Reprod Med 2005;23:242-247.
62. Cha KY, Koo JJ, Ko JJ, Choi DH, Han SY, Yoon TK: Pregnancy after in vitro fertilization of human follicular oocytes collected from nonstimulated cycles, their culture in vitro and their transfer in a donor oocyte program. Fertil Steril 1991;55:109-113.
63. Liao KL, Wood N, Conway GS: Premature menopause and psychological well-being. J Psychosom Obstet Gynaecol 2000;21:167-174.
64. Schmidt PJ, Cardoso GM, Ross JL, Haq N, Rubinow DR, Bondy CA: Shyness, social anxiety, and impaired self-esteem in Turner syndrome and premature ovarian failure. JAMA 2006 22;295:1374-1376.
65. Groff AA, Covington SN, Halverson LR, Fitzgerald OR, Vanderhoof V, Calis K, Nelson LM: Assessing the emotional needs of women with spontaneous premature ovarian failure. Fertil Steril 2005;83:1734-1741.